Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome.
J C
JC
Poupelin
F
F
Philit
J C
JC
Richard
M
M
Badet
S
S
Lemasson
F
F
Bayle
C
C
Guérin
D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy* / Q000503:physiopathology; D005602:France; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D010496:Pericardium / Q000000981:diagnostic imaging / Q000503:physiopathology*; D010994:Pleura / Q000503:physiopathology*; D011743:Pyrimidines / Q000008:administration & dosage / Q000627:therapeutic use*; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D014463:Ultrasonography; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole